NanoFUSE Biologics appoints Dr. Alok Sharan to scientific advisory board

Alok Sharan, MD, was recently appointed to the scientific advisory board at NanoFUSE Biologics.

Advertisement

Four things to know:

1. NanoFUSE Biologics is a bioactive glass designed for use in combination with demineralized bone matrix.

2. Dr. Sharan is co-director of the Westmed Spine Center in Yonkers, N.Y., and deputy editor of Clinical Spine Surgery.

3. He focuses on minimally invasive and cervical spine surgery. He completed his 100th successful awake spinal fusion procedure in July.

4. Dr. Sharan earned a master’s degree in healthcare management from Hanover, N.H.-based Dartmouth College in 2015.

More articles on biologics:
2 hospitals losing neurosurgery residency programs
Rothman, Carrum Health partner to expand healthcare benefits into tri-state area
Nexxt Spine to expand headquarters — 4 insights 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.